Article
Globular adiponectin but not full-length adiponectin induces increased procoagulability in human endothelial cells.
Department of Cardiology and Pneumology, Charité - Universitätsmedizin Medizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, D-12203 Berlin, Germany.
Journal of Molecular and Cellular Cardiology (impact factor:
5.17).
02/2008;
44(2):388-94.
DOI:10.1016/j.yjmcc.2007.10.018
pp.388-94
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Role of the phosphatidylinositol 3-kinase/protein kinase B pathway in regulating alternative splicing of tissue factor mRNA in human endothelial cells.
[show abstract] [hide abstract]
ABSTRACT: Tissue factor (TF) is the primary initiator of blood coagulation. In response to tumor necrosis factor (TNF)-alpha human umbilical vein endothelial cells (HUVECs) express 2 TF isoforms: a soluble alternatively spliced isoform (asHTF) and membrane-bound "full length" (fl)TF. How the differential TF isoform expression is regulated is still unknown. This study compared the impact of PI3K/Akt pathway inhibition on alternative splicing of TF in HUVECs, to the influence of transcriptional regulation by inhibiting nuclear factor kappa B (NFkappaB). The mRNA expression of TF isoforms was assessed by real-time PCR, the thrombogenic activity was measured by a chromogenic TF activity assay and the phosphorylation state of serine/arginine-rich (SR) proteins was analyzed by western blotting. Transfection of HUVECs was done 72 h before the inhibition experiments were performed. PI3K/Akt pathway inhibition reduced the mRNA expression of asHTF but not flTF. Inhibition of NFkappaB reduced the expression of both isoforms. Moreover, the PI3K/Akt pathway inhibition, but not that of NFkappaB, modified the phosphorylation of the SR proteins SRp75, SRp55 and SF2/ASF. Additionally, overexpression of SF2/ASF and SRp75 influenced the differential TF-isoform expression in HUVECs. The PI3K/Akt pathway modulates alternative splicing of TF in HUVECs, distinct from transcriptional regulation.Circulation Journal 08/2009; 73(9):1746-52. · 3.77 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
3 microg/mL
cellular procoagulability
chromogenic assay
data support
discovered adipocytokine
extrinsic coagulation system
fAPN
gAPN
gAPN stimulation
gAPN-induced rise
human serum
human umbilical vein endothelial cells
independent biological activities
MAP kinases ERK1/2
non-stimulated control
procoagulant effects
proteolytic cleavage product
TF activity
TF upregulation
western blot